Todd Kinsella
Corporate Officer/Principal bei Vividion Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Todd Kinsella
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.
20
| Subsidiary | Miscellaneous Commercial Services | 20 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Todd Kinsella
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| BOUNDLESS BIO, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| Duke University Medical Center | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| METACRINE, INC. | Biotechnology | Director/Board Member Founder | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Connecticut | College/University | Undergraduate Degree Graduate Degree | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| SEER, INC. | Biotechnology | Director/Board Member | |
| REVOLUTION HEALTHCARE ACQUISITION CORP. | Financial Conglomerates | Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| The University of California, San Francisco | College/University | Director/Board Member | |
| University of Greifswald | College/University | Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA. | Medical Specialties | Director/Board Member | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Corporate Officer/Principal | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Jewish Federation of Omaha, Inc.
 Jewish Federation of Omaha, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Federation of Omaha, Inc. offers social, educational and cultural programs through fundraising. It supports communal services in the Omaha area by establishing and accumulating assets for permanent funding resources. The company was founded in 1903 and is headquartered in Omaha, NE. | Miscellaneous Commercial Services | Director/Board Member | |
| American Association For Cancer Research Foundation | Director/Board Member | ||
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Deutschland | 4 |
| Schweiz | 3 |
| Argentinien | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 7 |
Operativ
| Director/Board Member | 146 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 43 |
| Founder | 24 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Kristina Burow | 43 |
| Richard Heyman | 33 |
| Catherine Friedman | 20 |
| Benjamin Cravatt | 19 |
| Jakob Loven | 19 |
| Jeffrey Hatfield | 18 |
| Fred Aslan | 16 |
| Christine Siu | 15 |
| Patricia Allen | 14 |
| Diego Miralles | 14 |
| Marianne de Backer | 14 |
| Christian Rommel | 11 |
| Robert T. Abraham | 9 |
| Aleksandra Rizo | 8 |
| Stefan Oelrich | 6 |
- Börse
- Insiders
- Todd Kinsella
- Unternehmensverbindungen
